• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Chemotherapy-induced cardiotoxicity in women.

作者信息

Dempsey Kelli S

机构信息

American Cancercare, 2613 E. Walnut Street, Evansville, IN 47714, USA.

出版信息

Crit Care Nurs Clin North Am. 2008 Sep;20(3):343-50. doi: 10.1016/j.ccell.2008.03.004.

DOI:10.1016/j.ccell.2008.03.004
PMID:18644518
Abstract

Chemotherapy-induced cardiotoxicity (CIC) is a major complication found with some life-saving medications used to treat breast and other cancers. Cardiotoxicity may present immediately during treatment or years later. These patients need education, screening, preventive measures, prompt interventions, and proper follow-up. This article focuses on CIC in patients who have breast cancer, but the process of evaluation and treatment design applies to all types of cancer and organ toxicities. Comprehensive pretreatment history, examination, and testing are needed for proper diagnosis and staging. CIC and other toxicities need to be considered in drug selection, treatment sequencing, testing, and appropriate follow-up.

摘要

相似文献

1
Chemotherapy-induced cardiotoxicity in women.
Crit Care Nurs Clin North Am. 2008 Sep;20(3):343-50. doi: 10.1016/j.ccell.2008.03.004.
2
Chemotherapy-induced cardiotoxicity in women.化疗导致的女性心脏毒性。
Heart Fail Clin. 2011 Jul;7(3):427-35. doi: 10.1016/j.hfc.2011.04.004.
3
Adjuvant therapy for HER2 positive breast cancer: are anthracyclines still necessary?HER2阳性乳腺癌的辅助治疗:蒽环类药物仍然有必要使用吗?
Clin Adv Hematol Oncol. 2008 Sep;6(9):666-72.
4
Reversibility of trastuzumab cardiotoxicity: is the concept alive and well?曲妥珠单抗心脏毒性的可逆性:这个概念还存在且适用吗?
J Clin Oncol. 2007 Dec 1;25(34):5532-3; author reply 5533-4. doi: 10.1200/JCO.2007.14.0657.
5
Trastuzumab-related cardiotoxicity following anthracycline-based adjuvant chemotherapy: how worried should we be?蒽环类辅助化疗后曲妥珠单抗相关心脏毒性:我们应多担忧?
J Clin Oncol. 2010 Jul 20;28(21):3407-10. doi: 10.1200/JCO.2009.26.0125. Epub 2010 Jun 7.
6
Re: Therapy Insight: anthracyclines and trastuzumab--the optimal management of cardiotoxic side effects.关于:治疗洞察:蒽环类药物与曲妥珠单抗——心脏毒性副作用的最佳管理
Nat Clin Pract Oncol. 2008 Nov;5(11):E1. doi: 10.1038/ncponc1275.
7
Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility.曲妥珠单抗相关的心脏毒性:对可逆性概念提出质疑。
J Clin Oncol. 2007 Aug 10;25(23):3525-33. doi: 10.1200/JCO.2007.11.0106.
8
Cardiac risks in multimodal breast cancer treatment.多模式乳腺癌治疗中的心脏风险
Strahlenther Onkol. 2007 Dec;183 Spec No 2:9-10. doi: 10.1007/s00066-007-2004-7.
9
[Therapy concept: herceptin with anthracyclines].[治疗理念:赫赛汀联合蒽环类药物]
Onkologie. 2002 Dec;25 Suppl 5:19-21; discussion 21.
10
Troponin I provides insight into cardiotoxicity and the anthracycline-trastuzumab interaction.肌钙蛋白I有助于深入了解心脏毒性以及蒽环类药物与曲妥珠单抗的相互作用。
J Clin Oncol. 2010 Sep 1;28(25):3901-4. doi: 10.1200/JCO.2010.30.6274. Epub 2010 Aug 2.

引用本文的文献

1
Cardiotoxicity of Anticancer Therapeutics.抗癌治疗的心脏毒性
Front Cardiovasc Med. 2018 Feb 7;5:9. doi: 10.3389/fcvm.2018.00009. eCollection 2018.